Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation
暂无分享,去创建一个
Max A. Viergever | Casper Beijst | Marnix G. E. H. Lam | Britt Kunnen | Hugo W. A. M. de Jong | M. Viergever | B. Kunnen | H. de Jong | M. Lam | C. Beijst
[1] Marnix G. E. H. Lam,et al. The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay , 2019, Clinical and Translational Imaging.
[2] Alexander S. Pasciak,et al. Radioembolization and the Dynamic Role of 90Y PET/CT , 2014, Front. Oncol..
[3] Marnix G. E. H. Lam,et al. Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization , 2013, PloS one.
[4] Ronald Boellaard,et al. Performance Characteristics of the Digital Biograph Vision PET/CT System , 2019, The Journal of Nuclear Medicine.
[5] Ronald Boellaard,et al. Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT , 2020, The Journal of Nuclear Medicine.
[6] Marnix G. E. H. Lam,et al. Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study , 2017, European Radiology.
[7] Martin A Lodge,et al. Comparison of quantitative Y-90 SPECT and non-time-of-flight PET imaging in post-therapy radioembolization of liver cancer. , 2016, Medical physics.
[8] Abass Alavi,et al. Insights into the Dose–Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases , 2016, The Journal of Nuclear Medicine.
[9] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[10] Denis Mariano-Goulart,et al. Retrospective voxel-based dosimetry for assessing the body surface area model ability to predict delivered dose and radioembolization outcome , 2018 .
[11] Maurizio Conti,et al. Characterization of 176Lu background in LSO-based PET scanners , 2017, Physics in medicine and biology.
[12] Jeroen Mertens,et al. 99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Max A. Viergever,et al. Radioembolization lung shunt estimation based on a 90Y pretreatment procedure: A phantom study , 2018, Medical physics.
[14] Marnix G E H Lam,et al. 99mTc-Macroaggregated Albumin Poorly Predicts the Intrahepatic Distribution of 90Y Resin Microspheres in Hepatic Radioembolization , 2013, The Journal of Nuclear Medicine.
[15] Ashfaq Mahmood,et al. Adsorption of metallic radionuclides on plastic phantom walls. , 2008, Medical physics.
[16] P. Goa,et al. Quantitative comparison of PET performance—Siemens Biograph mCT and mMR , 2016, EJNMMI Physics.
[17] Marcus Hacker,et al. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors , 2015, The Journal of Nuclear Medicine.
[18] S. Cheenu Kappadath,et al. Comparison of Step-and-Shoot and Continuous-Bed-Motion PET Modes of Acquisition for Limited-View Organ Scans , 2017, The Journal of Nuclear Medicine Technology.
[19] Denis Mariano-Goulart,et al. Retrospective Voxel-Based Dosimetry for Assessing the Ability of the Body-Surface-Area Model to Predict Delivered Dose and Radioembolization Outcome , 2018, The Journal of Nuclear Medicine.
[20] T. Hellevik,et al. Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation , 2014, Front. Oncol..
[21] Michael Tapner,et al. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[22] Gary D Hutchins,et al. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma. , 2014, Journal of vascular and interventional radiology : JVIR.
[23] S. Gulec,et al. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] Carlo Morosi,et al. Yttrium‐90 radioembolization for intermediate‐advanced hepatocellular carcinoma: A phase 2 study , 2013, Hepatology.
[25] J C Hung,et al. Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. , 2000, Journal of the American Pharmaceutical Association.
[26] Marnix G E H Lam,et al. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres , 2015, The Journal of Nuclear Medicine.
[27] Max A. Viergever,et al. Feasibility of imaging 90Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning , 2019, Medical physics.
[28] Johan Nuyts,et al. Bias Reduction for Low-Statistics PET: Maximum Likelihood Reconstruction With a Modified Poisson Distribution , 2015, IEEE Transactions on Medical Imaging.
[29] Yuni K. Dewaraja,et al. Prediction of Tumor Control in 90Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics , 2019, The Journal of Nuclear Medicine.
[30] Casper Beijst,et al. The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases , 2019, European Journal of Nuclear Medicine and Molecular Imaging.